Asian subgroup analysis of the REMISSIO study: A long-term efficacy and safety study of paliperidone palmitate 3-month formulation in patients with stable schizophrenia in a naturalistic clinical setting

• Main Authors: Chung, Young-Chul, Yang, Yen Kuang, Sulaiman, Ahmad Hatim, Bergmans, Paul, Tan, Wilson
• Format: Article
• Published: Korean Coll Neuropsychopharmacology 2022
• Subjects: RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry; RM Therapeutics. Pharmacology
• Online Access: http://eprints.um.edu.my/41555/

Objective: To evaluate the long-term efficacy and safety of three-monthly paliperidone palmitate (PP3M) in Asian patients with stable schizophrenia in a naturalistic setting. Methods: Asian patients recruited between May 2016 and March 2018 from the prospective, single-arm, non-randomized, open-labe...